From: What are we measuring? A critique of range of motion methods currently in use for Dupuytren’s disease and recommendations for practice
Frequency (n=)
1 ROM measure reported
[11–16, 18–21, 25–27, 29, 31–39, 45–49, 52, 55–57, 60–64, 70–74, 76, 79–88, 90–95, 97, 100]
61
2 ROM measures reported
[17, 22, 23, 40, 43, 51, 53, 54, 58, 59, 65–69, 75, 77, 78, 98, 99]
20
3 ROM measures reported
[24, 28, 30, 41, 42, 44, 50, 89, 96]
9
